Inspire Investing’s Immune Design Corp. IMDZ Stock Holding History

Inspire Investing’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-113	Closed	–	–	915
2017 Q4	$0	Buy	+113	New	+$615	﹤0.01%	931

Other funds holding IMDZ

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Inspire Investing's IMDZ Position: Q1 2018 in Review

Inspire Investing sold out of Immune Design Corp. (IMDZ) in Q1 2018, closing a stake of 113 shares.

Inspire Investing first reported a position in IMDZ in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 72 funds tracked by Wall St. Rank hold IMDZ as of Q1 2018.

Inspire Investing reported no remaining Immune Design Corp. position as of Q1 2018 after selling out during the quarter.
Inspire Investing sold 113 Immune Design Corp. shares in Q1 2018.
Inspire Investing first reported a position in Immune Design Corp. in Q4 2017 and held it in 1 quarter.
Inspire Investing's Immune Design Corp. position peaked at $0 in Q4 2017.
72 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2018.

Based on Inspire Investing's 13F filing for Q1 2018, filed 13 Apr 2018.